NCT04900974View on ClinicalTrials.gov

Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 9, 2022

Primary Completion Date

March 27, 2025

Study Completion Date

April 8, 2025

Conditions
HIV InfectionsPregnancy Related
Interventions
DRUG

Doravirine

100mg

Trial Locations (1)

27514

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER